Brain Activity During Gait in Parkinson's
- Conditions
- Parkinson Disease
- Interventions
- Other: Auditory CueingOther: Visual CueingOther: tactile Cueing
- Registration Number
- NCT04863560
- Lead Sponsor
- Northumbria University
- Brief Summary
Lay Summary:
Walking problems, such as slow and short steps, are very common in Parkinson's disease and lead to increased falls risk, as well as reduced mobility and quality of life. Walking issues are difficult to treat as medication interventions do not restore walking ability in people with Parkinson's, therefore physiotherapy approaches are used to help improve walking. Various physiotherapy strategies have been used, such as internal (thinking about bigger steps) or external prompts. External prompts include auditory (a metronome beat to step in time to), visual (lines to step over on the floor) and tactile (metronome-like vibration to step with) prompts that are very commonly used to improve walking in Parkinson's. However, the reason why walking improves in people with Parkinson's with these physiotherapy strategies is unknown, which has led to not all patients benefiting and only short-term walking improvements being seen.
The main issues are that it is unclear if these various internal or external prompt strategies are effective with the progression of Parkinson's disease, and it is unknown which type of strategy is most effective at different disease stages or with more severe walking impairment, such as freezing (the inability to progress walking for short periods despite wanting to do so). Being able to use specific brain regions to pay attention to different internal or external prompts has been suggested to be the reason why people with Parkinson's can overcome their walking problems, but this has not been tested. Therefore, this study will use state-of-the-art digital technology to measure walking and brain activity changes with different internal and external prompts. The investigators think that the walking improvement with different prompt strategies relies on the ability to activate specific brain regions, and that brain region activity in response to internal or external prompts will change at different stages of Parkinson's disease.
Ultimately, understanding the reasons why people benefit from these physiotherapy strategies and who benefits most from specific strategies will enable clinicians to provide more timely and efficient treatment for people with Parkinson's, and to develop more effective strategies to further improve walking.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
- Clinical diagnosis of Parkinson's by a movement disorder specialist according to United Kingdom (UK) brain bank criteria
- Hoehn & Yahr (H&Y) stage I-III
- Aged >50 years
- Able to walk and stand unaided
- Adequate hearing (as evaluated by the whisper test; stand 2m behind subject and whisper a 2 syllable word, subject repeats word) and vision capabilities (as measured using a Snellen chart - 6/18-6/12).
- Stable medication for the past 1 month and anticipated over a period of 6 months
- Psychiatric co-morbidity (e.g., major depressive disorder as determined by Geriatric Depression Scale - short form (GDS-15); <10 [26])
- Clinical diagnosis of dementia or other severe cognitive impairment (Montreal cognitive assessment <21 [27])
- History of stroke, traumatic brain injury or other neurological disorders (other than PD, for the PD group)
- Acute lower back or lower extremity pain, peripheral neuropathy, rheumatic and orthopaedic diseases
- Unstable medical condition including cardio-vascular instability in the past 6 months
- Unable to comply with the testing protocol or currently participating in another interfering research project
- Interfering therapy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Hoehn & Yahr stage I (H&YI) Auditory Cueing - 20 Hoehn \& Yahr stage I (early disease, minimal symptoms) Hoehn & Yahr stage I (H&YI) tactile Cueing - 20 Hoehn \& Yahr stage I (early disease, minimal symptoms) Hoehn & Yahr stage II (H&YII) Auditory Cueing - 30 Hoehn \& Yahr stage II (mild disease, no balance issues) Hoehn & Yahr stage III (H&YIII) Visual Cueing - 30 Hoehn \& Yahr stage III (moderate disease, balance issues) Hoehn & Yahr stage I (H&YI) Visual Cueing - 20 Hoehn \& Yahr stage I (early disease, minimal symptoms) Hoehn & Yahr stage II (H&YII) Visual Cueing - 30 Hoehn \& Yahr stage II (mild disease, no balance issues) Hoehn & Yahr stage II (H&YII) tactile Cueing - 30 Hoehn \& Yahr stage II (mild disease, no balance issues) Hoehn & Yahr stage III (H&YIII) Auditory Cueing - 30 Hoehn \& Yahr stage III (moderate disease, balance issues) Hoehn & Yahr stage III (H&YIII) tactile Cueing - 30 Hoehn \& Yahr stage III (moderate disease, balance issues)
- Primary Outcome Measures
Name Time Method Change in cortical oxygenated hemoglobin (HbO2) signal during walking immediately after intervention Change in cortical oxygenated hemoglobin (HbO2) measured while walking with cueing, which will be quantified with a wireless functional near infrared spectroscopy (fNIRS) system
Change in cortical power spectral densities during walking immediately after intervention Change in cortical power spectral densities of EEG signals from cortex with cueing, which will be quantified with a mobile electroencephalography (EEG) system
- Secondary Outcome Measures
Name Time Method Change in Stride Length (m) immediately after intervention Change in stride length with cueing
Change in Gait Speed (m/s) immediately after intervention Change in speed of walking with cueing
Change in Stride Time (s) immediately after intervention Change in time taken to complete a stride when walking with cues
Change in Gait Variability (SD) immediately after intervention Change in variability (standard deviation; SD) of gait when walking with cues
Trial Locations
- Locations (3)
Northumbria University
π¬π§Newcastle upon Tyne, United Kingdom
Oregon Health & Science University
πΊπΈPortland, Oregon, United States
Northumbria Healthcar NHS foundation trust
π¬π§North Shields, United Kingdom